Assistant Professor of the Department of BSMMU lever Mamun-Al-Mahtab said, they satansarao the new drug application for more than 60 patients have achieved success. Currently, the treatment will cost only five thousand rupees. With the beginning of commercial production of the medicine in the future, it will be reduced further. But now that hepatitis B immune maduletim against the drugs, the cost of treatment with interferon pegaileteda the five to 10 lakh. Said. The dreamer, they have come so far without foreign donations of any kind.
He expressed gratitude to the two men. Everyone who took part in the trials and the comprehensive cooperation. One of them, Sheikh Mohammed Fazle Akbar Japan Bangladeshi liver specialist. One of these trials under the supervision of the experiment is done in Japan. And the other lever of Bangabandhu Sheikh Mujib Medical University professor of selimura Rahman. Bangabandhu Sheikh Mujib Medical University Vice-Chancellor Prof Pran Gopal Dutta expressed an interest in the trial. His stay at Bangabandhu Sheikh Mujib Medical University of the medicine in the next two months, phase II / 3 trial to begin. The researchers are hopeful that within the next one and a half year phase-II / 3 at the end of trial, they can complete the drug patents and registration in the country. This will be the first country in the first rejistresanaprapta drugs. As a result of the poor patients infected with the hepatitis B treatment will be offered at a nominal price.
